NCT00583791|CompletedResultsDMC
Loading search results
Sponsor study identifier
Secondary identifiers
interventional
91
1 country
11
Study Start
July 2000
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2008
Actual (reported)Study Completion
November 2009
Actual (reported)The objective is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction with other congenital heart defects in infants and children.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2000
Date type not reportedThis date has not been verified as actual or estimated.
December 20, 2007
Actual (reported)December 31, 2007
Actual (reported)October 2008
Actual (reported)November 2009
Actual (reported)June 28, 2019
Actual (reported)Closure of Muscular Ventricular Septal Defects
Closure of muscular ventricular septal defect with the AMPLATZER Muscular VSD Occluder
5 years
Device closure with the AMPLATZER Muscular VSD Occluder for patients with muscular ventricular septal defects which are hemodynamically significant and are either isolated or present in conjunction with other congenital heart defects.
Device: AMPLATZER Muscular VSD Occluder
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Children's Hospital
Denver, Colorado, 80218, United States
Arnold Palmer Hospital
Orlando, Florida, 32806, United States
University of Chicago
Chicago, Illinois, 60637-1470, United States
University of Michigan Health System
Ann Arbor, Michigan, 48109-0316, United States
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Washington University Medical Center
St Louis, Missouri, 63110, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68198-2045, United States
Daniel Levi, MD
University of California, Los Angeles
91 participants (actual enrollment reported by the registry).
First Submitted
December 20, 2007
First Posted
December 31, 2007
Study Start
July 2000
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Columbus Children's Hospital
Columbus, Ohio, 43205, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Children's Hospital of the King's Daughters
Norfolk, Virginia, 30322, United States
Children's Hospital and Regional Medical Center
Seattle, Washington, 98105, United States
Primary Completion
October 2008
Actual (reported)Study Completion
November 2009
Actual (reported)Last Updated
June 28, 2019
Results First Posted
June 28, 2019
Record last verified: 2016-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: